Both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) can stimulate pancreatic beta cells to secrete insulin in a glucose-dependent manner to control blood glucose levels, with hypoglycemia occurring very rarely as an adverse effect [25]. Here, GIP is linked to Hypoglycemia.